We may earn a commission from partner links. It never changes our math or the order.How we make money
Comparison

Mochi vs Fridays for GLP-1 weight loss

Compare Mochi first if you want a clearer membership-plus-medication structure.

Side by side

How we score
Membership model

From$79/mo

$0 first month (promotional), then $79/mo membership + meds

Source: Mochi homepage · Checked

Visit Partner link
Promo pricing

Not published

Promo pricing varies by plan

Source: Fridays pricing page · Checked

Check this: Checked over 30 days ago.

Confirm prices at checkout.

Visit Partner link
Full comparison table
Side-by-side comparison of Mochi vs Fridays for GLP-1 weight loss
ProviderScoreFrom priceMedsBest for
Mochi Health4.0$79/mo$0 first month (promotional), then $79/mo

Source: Mochi homepage · Checked

Billed separatelyLow-cost compounded membership
Fridays3.9Not publishedPromo pricing varies by plan; verify live checkout

Source: Fridays pricing page · Checked

Varies by planPromo-driven compounded plans

Good for

  • Mochi: users who want membership, provider access and care-team messaging emphasized.
  • Fridays: users comparing visible promotional pricing and bundled lifestyle support.
  • Both: users who understand compounded-product caveats.

Read the comparison

Comparison standard

Keep the comparison focused on verifiable differences: medication path, advertised price, membership terms, product type, support model and final checkout questions.

  • Normalize cost
  • Name product type
  • Link to provider reviews

Pricing structure

Mochi public pages describe a membership that includes provider and care-team access, while medications and diagnostics can be separate. Fridays public pricing emphasizes promotional monthly medication/program pricing.

  • Compare the same plan length for both providers.
  • Separate membership, medication, labs and shipping.
  • Check the renewal price after any promotion.

Compounded medication caveat

Both providers can surface compounded GLP-1 options. That does not mean the products are equivalent to FDA-approved Wegovy or Zepbound. Ask about pharmacy source, formulation, dose instructions and what happens as FDA compounding policy changes.

  • Ask whether the product is FDA-approved or compounded.
  • Avoid products with unclear active ingredient language.
  • Read FDA warnings before choosing solely by price.

How to choose

Choose Mochi first if you value a membership with clear care-team access. Choose Fridays first if the advertised promotional price is the main reason you are shopping and you are comfortable checking plan length and refund terms. Either way, the safest comparison happens after intake quote, not before.

  • Keep the final checkout terms before paying.
  • Ask what is included in support beyond the prescription.
  • Compare against a brand-name pathway if FDA-approved medication is your priority.

Quick answers

What is the fairest way to compare these options?

Use the same evidence set for each option: total recurring quote, medication path, support model, source quality and unresolved checkout questions.

Sources (7)

Sources

  1. Mochi Health official siteOfficial Mochi program and pricing language.
  2. Fridays pricingOfficial Fridays GLP-1 program/pricing language.
  3. FDA concerns with unapproved GLP-1 drugsFDA safety context for unapproved GLP-1 products.
  4. Mochi Health FAQOfficial FAQ page for care, support and common program claims.
  5. Fridays: pricing pageOfficial Fridays pricing page; promotional pricing and plan terms can change.
  6. Fridays: GLP-1 weight-loss pageOfficial Fridays program page describing brand-name and compounded medication pathways.
  7. FDA: GLP-1 supply stabilization and compounding policy updateFDA update on semaglutide and tirzepatide shortage status and compounding enforcement timelines.

Verify before purchase

  • Final checkout quote after eligibility screening
  • Medication type, pharmacy route and FDA-approved or compounded status
  • Renewal, cancellation, refund and refill terms
Read the full comparison

What to verify

  • Final checkout quote after eligibility screening
  • Medication type, pharmacy route and FDA-approved or compounded status
  • Renewal, cancellation, refund and refill terms
Review overview

Compare these providers by total recurring quote, compounded-product language, support model and source clarity.

Last checked Jul 5, 2026

Grocery aisle representing weekly support and planning.

Comparison standard

Keep the comparison focused on verifiable differences: medication path, advertised price, membership terms, product type, support model and final checkout questions.

  • Normalize cost
  • Name product type
  • Link to provider reviews

Pricing structure

Mochi public pages describe a membership that includes provider and care-team access, while medications and diagnostics can be separate. Fridays public pricing emphasizes promotional monthly medication/program pricing.

  • Compare the same plan length for both providers.
  • Separate membership, medication, labs and shipping.
  • Check the renewal price after any promotion.

Compounded medication caveat

Both providers can surface compounded GLP-1 options. That does not mean the products are equivalent to FDA-approved Wegovy or Zepbound. Ask about pharmacy source, formulation, dose instructions and what happens as FDA compounding policy changes.

  • Ask whether the product is FDA-approved or compounded.
  • Avoid products with unclear active ingredient language.
  • Read FDA warnings before choosing solely by price.
The check we would not skip
Compounded GLP-1 products are not FDA-approved.
The check we would not skip · CravingWise research desk

How to choose

Choose Mochi first if you value a membership with clear care-team access. Choose Fridays first if the advertised promotional price is the main reason you are shopping and you are comfortable checking plan length and refund terms. Either way, the safest comparison happens after intake quote, not before.

  • Keep the final checkout terms before paying.
  • Ask what is included in support beyond the prescription.
  • Compare against a brand-name pathway if FDA-approved medication is your priority.
Side-by-side comparison

Read the full comparison

Side-by-side comparison of Mochi vs Fridays for GLP-1 weight loss
ProviderScoreFrom priceMedsBest for
Mochi Health4.0/5$79/mo$0 first month (promotional), then $79/mo

Source: Mochi homepage · Checked

Billed separatelyLow-cost compounded membership
Fridays3.9/5Not publishedPromo pricing varies by plan; verify live checkout

Source: Fridays pricing page · Checked

Checked · confirm at checkout

Varies by planPromo-driven compounded plans
More questions and context

Decision filter

Compare the compounded-care details line by line

A comparison is useful only when it separates confirmed facts from terms that still depend on eligibility, insurance, dose or checkout.

  • Cost
  • Medication path
  • Support model
  • Open questions

Common questions

What is the fairest way to compare these options?

Use the same evidence set for each option: total recurring quote, medication path, support model, source quality and unresolved checkout questions.

Educational content only. Do not use this page as medical advice or as a substitute for a licensed clinician, pharmacist or insurer reviewing your situation.

Related checks
Sources and what to verify (7)

Sources

  1. Mochi Health official site

    Official Mochi program and pricing language.

  2. Fridays pricing

    Official Fridays GLP-1 program/pricing language.

  3. FDA concerns with unapproved GLP-1 drugs

    FDA safety context for unapproved GLP-1 products.

  4. Mochi Health FAQ

    Official FAQ page for care, support and common program claims.

  5. Fridays: pricing page

    Official Fridays pricing page; promotional pricing and plan terms can change.

  6. Fridays: GLP-1 weight-loss page

    Official Fridays program page describing brand-name and compounded medication pathways.

  7. FDA: GLP-1 supply stabilization and compounding policy update

    FDA update on semaglutide and tirzepatide shortage status and compounding enforcement timelines.